Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
08/2014
08/13/2014CN103305212B 波长可调的二芳乙烯基喹喔啉哒嗪酮类有机发光材料及其制备方法 Second aromatic vinyl quinoxaline Pyridazinone organic light-emitting material and method wavelength tunable
08/13/2014CN103113355B 一种Bcr/Abl酪氨酸激酶抑制剂及其制备方法和在治疗慢性粒细胞白血病中的应用 One kind of Bcr / Abl tyrosine kinase inhibitor and its preparation method and application in the treatment of chronic myeloid leukemia
08/13/2014CN103068819B 杂环抗病毒化合物 Heterocyclic Antiviral compounds
08/13/2014CN102702175B 一种吲哚-3-琥珀酰亚胺的制备方法 One kind of indole-3-succinimide prepared
08/13/2014CN102675401B 抗肿瘤药物lqc-y的制备及其应用 Preparation and Application of antineoplastic lqc-y
08/13/2014CN102596939B 用于有机发光二极管发射层的化合物 The organic compound layer for the light emitting diode
08/13/2014CN102344442B 一种枸橼酸坦度螺酮化合物的晶型及其制备方法和用途 One kind of compound citrate tandospirone crystalline form and its preparation method and use
08/13/2014CN102260246B 低毒性cb1受体抑制剂、其制备方法及其在制备戒毒、减肥或治疗糖尿病药物中的应用 Low toxicity cb1 receptor inhibitors, their preparation and their treatment in the preparation, diet or treatment of diabetes drug application
08/13/2014CN102216292B 四取代的哒嗪hedgehog途径拮抗剂 Tetra-substituted pyridazine hedgehog pathway antagonists
08/13/2014CN102015636B 作为组胺h3受体拮抗剂的氮杂环丁烷类和环丁烷类化合物 Azetidine as histamine h3 class and cyclobutane receptor antagonist compounds
08/12/2014US8802851 Process for preparing vilazodone hydrochloride
08/12/2014US8802679 Glycine compound
08/12/2014US8802678 Carbonylated (aza) cyclohexanes as dopamine D3 receptor ligands
08/12/2014US8802674 Aminopyrimidine derivatives as LRRK2 modulators
08/12/2014US8802673 Heterocyclic amine derivatives
08/12/2014US8802665 Pyrrolidine derivatives
08/12/2014US8802659 Bicyclic aryl sphingosine 1-phosphate analogs
08/12/2014US8802657 Compounds useful as Raf kinase inhibitors
08/12/2014CA2520225C Benzenesulfonamide derivatives
08/12/2014CA2508452C Triazine compounds and their use in forming multidimensional libraries for affinity chromatography
08/07/2014WO2014121062A1 Selective hdac3 inhibitors
08/07/2014WO2014121055A2 Flap modulators
08/07/2014WO2014121040A1 Flap modulators
08/07/2014WO2014120815A1 Quinoline and quinazoline amides as modulators of sodium channels
08/07/2014WO2014120683A1 Small-molecule inhibitors targeting g-protein-coupled rho guanine nucleotide exchange factors
08/07/2014WO2014065848A3 Compounds for treating papilloma virus infection
08/07/2014WO2011123751A3 Heterocyclic compounds and their use as pi3k inhibitors
08/07/2014US20140221421 Therapeutic compounds
08/07/2014US20140221403 Quinazoline based egfr inhibitors containing a zinc binding moiety
08/07/2014US20140221396 Tubulin inhibitors
08/07/2014US20140221391 Cyclohexane derivative compound
08/07/2014US20140221376 Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
08/07/2014US20140221375 Method for treating proliferative disorders associated with mutations in c-met
08/07/2014US20140221374 Raf kinase inhibitors
08/07/2014US20140221373 Arylpyrazole ethers as inhibitors of leukotriene a4 hydrolase
08/07/2014US20140221357 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
08/07/2014US20140221347 Therapeutic compounds
08/07/2014US20140221346 Therapeutic compounds
08/07/2014US20140221339 Heterocyclic Derivative and Pharmaceutical Drug
08/07/2014US20140221337 Potassium Channel Blockers
08/07/2014US20140221336 Compounds useful as inhibitors of janus kinases
08/07/2014US20140221335 Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
08/07/2014US20140221311 Flap modulators
08/07/2014US20140221310 Flap modulators
08/06/2014EP2762477A1 Material for organic electroluminescent element, and organic electroluminescent element produced using same
08/06/2014EP2762476A1 1,2,4-triazine-6-carboxamide derivative
08/06/2014EP2760857A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
08/06/2014EP2760856A1 Selective nr2b antagonists
08/06/2014EP2760844A1 Fluorogenic peptidase substrate
08/06/2014EP2760843A2 Selective nr2b antagonists
08/06/2014EP2760840A1 Quinolinone carboxamide inhibitors of endothelial lipase
08/06/2014EP2760831A1 Viral replication inhibitors
08/06/2014EP2760830A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
08/06/2014EP2760829A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
08/06/2014CN103974950A 作为ccr(4)拮抗剂的取代的苯并咪唑类和苯并吡唑类 As ccr (4) antagonists substituted benzimidazoles and benzo pyrazoles
08/06/2014CN103965171A 一种阿利沙坦酯的制备方法 Preparation method of Alicante medoxomil
08/06/2014CN103965170A 苯磺酰胺吡唑激酶抑制剂 Benzenesulfonamide pyrazolo kinase inhibitors
08/06/2014CN103965167A 咪唑羧酸衍生物 Imidazole carboxylic acid derivatives
08/06/2014CN103965117A 一类羟胺类化合物、制备方法及其用途 A class of hydroxylamine compounds, preparation and use
08/06/2014CN103003264B 嘧啶衍生物 Pyrimidine derivatives
08/06/2014CN102942559B 一种柔性醚氧链嘧啶衍生物、其制备方法及其用途 A flexible chain ether oxygen pyrimidine derivatives, their preparation and their use
08/06/2014CN102933577B 杀真菌的肟和腙 Fungicidal oxime and hydrazone
08/06/2014CN102083818B 被取代的1-(二嗪基)吡唑-4-基-乙酸、其制备方法及其作为除草剂和植物生长调节剂的用途 Substituted 1- (diazine-yl) pyrazol-4-yl - use acid, their preparation and their use as herbicides and plant growth regulators
08/06/2014CN102066361B 杂芳基取代的双环的smac模拟物及其用途 Heteroaryl substituted bicyclic smac mimetics and their use
08/06/2014CN101910152B 作为janus激酶抑制剂的4-吡唑基-n-芳基嘧啶-2-胺和4-吡唑基-n-杂芳基嘧啶-2-胺 As janus kinase inhibitors 4- pyrazolyl -n- aryl-pyrimidin-2-amine and 4-pyrazolyl -n- heteroaryl pyrimidin-2-amine
08/06/2014CN101868452B 螺环吡咯烷类与其对抗hcv和hiv感染的应用 Spiro Pyrrolidine hcv hiv infection and its application against
08/05/2014US8796473 Method for producing curing agent having acidic substituent and unsaturated maleimide group, thermosetting resin composition, prepreg, and laminate
08/05/2014US8796467 Compounds
08/05/2014US8796466 Hepatitis C virus inhibitors
08/05/2014US8796455 Fused bicyclic mTOR inhibitors
08/05/2014US8796449 s-Triazine compounds, pharmaceutical compositions and methods of using the same
08/05/2014US8796299 NK1 antagonists
08/05/2014US8796280 2,3-disubstituted pyrazinesulfonamides as CRTH2 inhibitors
08/05/2014US8796263 4-aminoquinazolin-2-yl-1-pyrrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitors
08/05/2014US8796259 N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as axl inhibitors
08/05/2014US8796253 Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
08/05/2014US8795691 Nanotubes and compositions thereof
08/05/2014CA2789711C Aryl carboxamide derivatives as sodium channel inhibitors for treatment of pain
08/05/2014CA2725045C Silent desensitizers of neuronal nachr and methods of use thereof
08/05/2014CA2591724C 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors
08/05/2014CA2565238C Amido compounds and their use as pharmaceuticals
07/2014
07/31/2014WO2014116768A1 Guanidine derivatives for the treatment of hepatitis c
07/31/2014WO2014114779A1 N-substituted-5-substituted phthalamic acids as sortilin inhibitors
07/31/2014WO2014114776A1 Quinoxalinones and dihydroquinoxalinones as respiratory syncytial virus antiviral agents
07/31/2014WO2014114695A1 New pyrimidine derivatives as phosphodiesterase 10 inhibitors (pde-10)
07/31/2014WO2014114446A1 Polymerizable dental composition
07/31/2014WO2014114250A1 Pyrazoline derivatives as insecticidal compounds
07/31/2014WO2013117288A8 Tetrahydro-quinazolinone derivatives as tank and parp inhibitors
07/31/2014US20140213788 Process for the preparation of alpha-acyloxy beta-formamido amides
07/31/2014US20140213704 New triazine derivative and ultraviolet absorber
07/31/2014US20140213623 Compounds for treatment of cancer
07/31/2014US20140213592 Protein Kinase Inhibitors (Variants), Use Thereof in Treating Oncological Diseases and a Pharmaceutical Composition Based Thereon
07/31/2014US20140213586 Viral replication inhibitors
07/31/2014US20140213574 Heteroaryl compounds and uses thereof
07/31/2014US20140213572 Unsaturated nitrogen heterocyclic compounds useful as pde10 inhibitors
07/31/2014US20140213570 1,4-disubstituted pyridazine analogs there of and methods for treating smn-deficiency-related conditions
07/31/2014US20140213554 Compounds and methods for kinase modulation, and indications therefor
07/31/2014US20140212509 Inhibitors of poly(adp-ribose)polymerase
07/30/2014EP2759535A1 CA-IX specific radiopharmaceuticals for the treatment and imaging of cancer
07/30/2014EP2759289A1 Polymerizable dental composition
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 626